Sign in
Active, not recruitingNo phase

Harmonic Ratio in Patients With GLUT1 Deficiency Syndrome

Key facts

Who runs it
IRCCS National Neurological Institute "C. Mondino" Foundation
Where
Italy2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
32 people enrolled
Started
1 Jan 2023
Expected to end
31 Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • Inertial gait analysis
Record updated
30 April 2024

Who can take part

Age
3 years to 60 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Pediatric and adult patients (range 3-60 years) diagnosed with GLUT1 deficiency syndrome according to the recommendations of the International Study Group (Klepper et al., 2020)
  • Ability to walk independently the necessary route
  • Compliance with study procedures
  • Typically developing healthy volunteers
  • Age range 3-60 years

Who cannot take part

  • Presence of other neurological or orthopedic comorbidities that may influence gait assessment
  • Poor compliance with study procedures; Healthy controls eligibility criteria:
  • Presence of neurological or orthopedic comorbidities that may influence gait assessment

Other criteria

  • Patients eligibility criteria

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Glucose transporter deficiency syndrome type 1 (GLUT1DS) is a rare, genetically determined, neurometabolic disorder .

Read full original descriptionShow less

It is estimated that about 90% of affected patients present various pathological gait patterns. Ataxic, spastic, ataxo-spastic, or dystonic walking are the main manifestations described to date.

The kinematic gait analysis with inertial sensors represents a method that is easily applicable in clinical practice, with possible application in numerous neurological syndromes of the pediatric and adult age.

Through the kinematic gait analysis, it will be possible to obtain an accurate characterization of the gait of patients with GLUT1DS. This will allow, in the first place, a better knowledge of locomotor parameters in this rare cohort of patients. Given that kinematic analysis through a wearable sensor is a method that can be easily integrated into daily clinical practice, the data obtained could become prognostic biomarkers and significant outcome measures of the disease (also in relation to possible improvements deriving from treatment with a ketogenic diet or in the context of future pharmacological trials).

The 2 groups in the trial

  • GLUT1DS

    Patients affected by GLUT1 deficiency syndrome

    Treatment: Inertial gait analysis

  • Healthy controls

    Age and sex matched healthy controls

    Treatment: Inertial gait analysis

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 April 2024